CCND1 and chronic myelogenous leukemia, BCR-ABL1 positive: A luciferase test validated that the 3′ UTR of CCND1 was a target of miR-342–5p Altered CCND1 expression has been identified as a factor in the progression of CML by facilitating cell cycle.